Doesn't change the deficiencies of the trial to keep posting the JAMA Oncology link. NWBO share price has now dropped below the price point PRIOR to the publication. So clearly investors aren't buying it. It is also below the lever when the TLD was released.
Just look at how successful biotechs shares responds -- big jump when positive data is released (NWBO had no positive response). And now facing serious dilution and loooooong wait for an application to be filed. Not positives for NWBO share price.
Market Data 
Markets 
AI
